Prolonged Multimodal Analgesia for Post-Discharge Pain Control After Primary Total Hip Arthroplasty



Status:Completed
Conditions:Arthritis, Osteoarthritis (OA)
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:18 - Any
Updated:1/31/2019
Start Date:June 5, 2017
End Date:February 28, 2018

Use our guide to learn which trials are right for you!

This is a prospective, three-arm, comparative study with a provider-crossover design. The
first arm will comprise the standard of care pain regimen after discharge, which comprises
PRN oxycodone, tramadol, and acetaminophen. The second arm will comprise a multimodal pain
regimen; however, patients will still be routinely provided PRN oxycodone and tramadol to use
on an as needed basis. The third arm will comprise a multimodal pain management protocol,
which does not routinely allow for opioid consumption. However, patients will be provided a
one week supply of oxycodone and tramadol for emergency pain relief only.


Inclusion Criteria:

- Patients undergoing unilateral, primary cementless THA with underlying diagnosis of
osteoarthritis.

- ASA I - III

- Spinal anesthesia

- Male and Female over 18 who are willing and able to provide informed consent

Exclusion Criteria:

- Opioid use within 3 months prior to surgery

- General anesthesia

- Non-english speaking

- ASA IV or greater

- Allergy/contraindications to protocol medications

- Renal insufficiency with Cr > 2.0 or hepatic failure

- Sensory/motor disorder involving the operative limb

- Planned or unplanned discharge to rehab

- Length of stay >3 days

- Revision or conversion THA

- Cigarette smokers
We found this trial at
1
site
Philadelphia, Pennsylvania 19107
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials